JP2024546121A5 - - Google Patents
Info
- Publication number
- JP2024546121A5 JP2024546121A5 JP2024534494A JP2024534494A JP2024546121A5 JP 2024546121 A5 JP2024546121 A5 JP 2024546121A5 JP 2024534494 A JP2024534494 A JP 2024534494A JP 2024534494 A JP2024534494 A JP 2024534494A JP 2024546121 A5 JP2024546121 A5 JP 2024546121A5
- Authority
- JP
- Japan
- Prior art keywords
- use according
- pharmaceutical composition
- malt1 inhibitor
- subject
- administration
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (13)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163288085P | 2021-12-10 | 2021-12-10 | |
| US202163288081P | 2021-12-10 | 2021-12-10 | |
| US202163288083P | 2021-12-10 | 2021-12-10 | |
| US63/288,085 | 2021-12-10 | ||
| US63/288,081 | 2021-12-10 | ||
| US63/288,083 | 2021-12-10 | ||
| US202263306655P | 2022-02-04 | 2022-02-04 | |
| US202263306660P | 2022-02-04 | 2022-02-04 | |
| US202263306657P | 2022-02-04 | 2022-02-04 | |
| US63/306,660 | 2022-02-04 | ||
| US63/306,657 | 2022-02-04 | ||
| US63/306,655 | 2022-02-04 | ||
| PCT/US2022/052450 WO2023107721A1 (en) | 2021-12-10 | 2022-12-09 | Methods for treating diseases using malt1 inhibitors |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024546121A JP2024546121A (ja) | 2024-12-17 |
| JP2024546121A5 true JP2024546121A5 (https=) | 2025-10-27 |
Family
ID=86731143
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024534494A Pending JP2024546121A (ja) | 2021-12-10 | 2022-12-09 | Ｍａｌｔ１阻害剤を使用して疾患を処置する方法 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20250032493A1 (https=) |
| EP (1) | EP4444340A4 (https=) |
| JP (1) | JP2024546121A (https=) |
| AU (1) | AU2022405443A1 (https=) |
| CA (1) | CA3240140A1 (https=) |
| WO (1) | WO2023107721A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN121419973A (zh) * | 2023-06-30 | 2026-01-27 | 詹森药业有限公司 | Malt1抑制剂 |
| WO2025082417A1 (zh) * | 2023-10-18 | 2025-04-24 | 苏州沙砾生物科技有限公司 | 一种表达融合蛋白的细胞及其应用 |
| WO2025223516A1 (zh) * | 2024-04-24 | 2025-10-30 | 首药控股(北京)股份有限公司 | 一种抑制剂杂环化合物 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TR201903280T4 (tr) * | 2011-08-02 | 2019-04-22 | Helmholtz Zentrum Muenchen Deutsches Forschungszentrum Gesundheit & Umwelt Gmbh | Malt1 proteazının fenotiazin türevleri ile selektif inhibisyonu. |
| EA201590916A1 (ru) * | 2012-11-09 | 2016-02-29 | Корнэлл Юниверсити | Низкомолекулярные ингибиторы malt1 |
| AU2016352813B2 (en) * | 2015-11-13 | 2019-09-19 | Novartis Ag | Novel pyrazolo pyrimidine derivatives |
| IL294214B2 (en) * | 2019-12-27 | 2026-04-01 | Schrodinger Inc | Cyclic compounds and methods for using them |
| WO2021207343A1 (en) * | 2020-04-08 | 2021-10-14 | Rheos Medicines, Inc. | Malt1 inhibitors and uses thereof |
-
2022
- 2022-12-09 EP EP22905193.3A patent/EP4444340A4/en active Pending
- 2022-12-09 US US18/715,889 patent/US20250032493A1/en active Pending
- 2022-12-09 CA CA3240140A patent/CA3240140A1/en active Pending
- 2022-12-09 WO PCT/US2022/052450 patent/WO2023107721A1/en not_active Ceased
- 2022-12-09 JP JP2024534494A patent/JP2024546121A/ja active Pending
- 2022-12-09 AU AU2022405443A patent/AU2022405443A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024546121A5 (https=) | ||
| Leung et al. | Colchicine—update on mechanisms of action and therapeutic uses | |
| Dahlöf et al. | Morbidity and mortality in the Swedish trial in old patients with hypertension (STOP-Hypertension) | |
| JP2025510295A5 (https=) | ||
| CN101031305A (zh) | 类风湿性关节炎的预防和/或治疗药物 | |
| JP2022188083A5 (https=) | ||
| CN113274384B (zh) | 驴食草酚在制备防治溃疡性结肠炎的药物中的应用及其药物 | |
| JP2005514414A5 (https=) | ||
| JP2019507786A5 (https=) | ||
| JP2016505050A5 (https=) | ||
| JP2023549849A5 (https=) | ||
| JP2024540439A5 (https=) | ||
| WO2023280238A1 (zh) | 一种包含绿原酸的药物组合物在制备治疗早期阿尔茨海默病的药物中的用途 | |
| JP2019507785A5 (https=) | ||
| JP6885649B2 (ja) | 統合失調症の治療のためのイロペリドン | |
| JP2019535830A5 (https=) | ||
| JP2022503771A5 (https=) | ||
| KR102854371B1 (ko) | 에트라비린의 대사성 질환 및 섬유화 질환 치료 용도 | |
| JP2014509656A5 (https=) | ||
| WO2020106191A1 (ru) | Производное глутаримида для преодоления резистентности к стероидам | |
| JP2022512158A5 (https=) | ||
| CN115243686B (zh) | 丁基苯酞及其衍生物的用途 | |
| JP7527662B2 (ja) | ピモジドとメトトレキサートの医薬組成物、及びその使用 | |
| Schwartz et al. | The Management of Massive Tuberculous Pneumonia, A Therapeutic Review of Seventy-Five Cases | |
| JP2025522146A5 (https=) |